Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years

Georgios Efthymiou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0243-1456; OpenAlex author ID A5046622859. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

  1. The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damage. Co-author DOI 10.1126/sciadv.adu2276↗
  2. SK2 channels set a signalling hub bolstering CAF-triggered tumourigenic processes in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2021-326610↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. François Bertucci · 2 shared papers, 2023–2025 · strength 0.35
  2. Zainab Hussain · 2 shared papers, 2023–2025 · strength 0.35
  3. Richard Tomasini · 2 shared papers, 2023–2025 · strength 0.35
  4. Fabienne Guillaumond · 1 shared paper, 2025 · strength 0.20
  5. Sophie Vasseur · 1 shared paper, 2025 · strength 0.20
  6. Corinne Bousquet · 1 shared paper, 2023 · strength 0.14
  7. Raphaël Rapetti‐Mauss · 1 shared paper, 2023 · strength 0.14
  8. Jérémy Nigri · 1 shared paper, 2023 · strength 0.14
  9. Olivier Soriani · 1 shared paper, 2023 · strength 0.14
  10. Nelson Dusetti · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.